In addition to TFE3 rearrangement, Macher-Goeppinger S et al. provided evidence that increased TFE3 expression resulting from gene amplification or epigenetic alterations was associated with unfavorable clinicopathological features, such as higher grade, the presence of metastatic disease and advanced tumor stage [8]. The gene discussed is TFE3; the disease is metastatic neoplasm.